Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Bela Peethambaran"'
Autor:
Vignesh Sivaganesh, Bela Peethambaran
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 6, Pp 1188-1209 (2023)
Aim: It is important to identify anti-cancer compounds that can inhibit specific molecular targets to eradicate androgen-receptor negative (ARneg), androgen-independent (AI) prostate cancer, which is an aggressive form of prostate cancer with limited
Externí odkaz:
https://doaj.org/article/fbb1e4bdcdaa4e45a8acaf7d3d700ed2
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 13, p 7003 (2024)
Androgen-receptor-negative, androgen-independent (ARneg-AI) prostate cancer aggressively proliferates and metastasizes, which makes treatment difficult. Hence, it is necessary to continue exploring cancer-associated markers, such as oncofetal Recepto
Externí odkaz:
https://doaj.org/article/831b84c48e3d4b68b8312a206a506978
Autor:
Shradheya R. R. Gupta, Tram M. Ta, Maryam Khan, Archana Singh, Indrakant K. Singh, Bela Peethambaran
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Introduction: Breast cancer is the most common cancer in women, with roughly 10–15% of new cases classified as triple-negative breast cancer (TNBC). Traditional chemotherapies are often toxic to normal cells. Therefore, it is important to discover
Externí odkaz:
https://doaj.org/article/81a0d7c3f84c410da28b4f272dfe0101
Autor:
Vignesh Sivaganesh, Varsha Sivaganesh, Christina Scanlon, Alexander Iskander, Salma Maher, Thư Lê, Bela Peethambaran
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 23, p 12865 (2021)
Protein tyrosine kinases, especially receptor tyrosine kinases, have dominated the cancer therapeutics sphere as proteins that can be inhibited to selectively target cancer. However, protein tyrosine phosphatases (PTPs) are also an emerging target. T
Externí odkaz:
https://doaj.org/article/c61c803e1fa640cda0637fc98e6bd0d2
Autor:
Norman Fultang, Abhinav Illendula, Brian Chen, Chun Wu, Subash Jonnalagadda, Nathan Baird, Zachary Klase, Bela Peethambaran
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217789 (2019)
Triple Negative Breast Cancer (TNBC), the most aggressive subtype of breast cancer, is characterized by the absence of hormone receptors usually targeted by hormone therapies like Tamoxifen. Because therapy success and survival rates for TNBC lag far
Externí odkaz:
https://doaj.org/article/74840e4721fa4152a067de9273003ae4
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 5, p 2433 (2021)
Immunotherapy is a highly emerging form of breast cancer therapy that enables clinicians to target cancers with specific receptor expression profiles. Two popular immunotherapeutic approaches involve chimeric antigen receptor-T cells (CAR-T) and bisp
Externí odkaz:
https://doaj.org/article/6f92b5dde38440acbef9a8ba60d89179
Autor:
Bela Peethambaran, Chelsea Menisa Leonce, Amrut Patel, Radha Gonsai, Austin Kim, Thu Le, Delghir Sanzhikov, Pranaya Chakravarthula, Kogila Vijayan, Amos Mugweru
Publikováno v:
International Journal of Complementary & Alternative Medicine. 15:160-168
Publikováno v:
International Journal of Complementary & Alternative Medicine. 14:17-24
Autor:
Thư Lê, Christina Scanlon, Varsha Sivaganesh, Bela Peethambaran, Vignesh Sivaganesh, Salma Maher, Alexander Iskander
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 12865, p 12865 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Protein tyrosine kinases, especially receptor tyrosine kinases, have dominated the cancer therapeutics sphere as proteins that can be inhibited to selectively target cancer. However, protein tyrosine phosphatases (PTPs) are also an emerging target. T
Publikováno v:
The FASEB Journal. 35